Skip to main content

Articles

Page 24 of 33

  1. Sertoli - Leydig cell tumors (SLCTs) are sex-cord stromal tumors that account less than 0.5 % of primary ovarian neoplasms. They are mostly benign and occur in reproductive age women. Variants with heterologou...

    Authors: T. Burnik Papler, S. Frković Grazio and B. Kobal
    Citation: Journal of Ovarian Research 2016 9:46
  2. Oviducts participate in fertilization and early embryo development, and they are influenced by systemic and local circulation. Local functional interplay between ovary, oviduct and uterus is important, as dedu...

    Authors: Rebeca López-Úbeda, Marta Muñoz, Luis Vieira, Ronald H. F. Hunter, Pilar Coy and Sebastian Canovas
    Citation: Journal of Ovarian Research 2016 9:44
  3. The aim of this study was to evaluate HE4, CA125 and ROMA in the preoperative differentiation benign ovarian diseases from epithelial ovarian cancer depending on the menopausal status.

    Authors: Katarzyna M. Terlikowska, Bozena Dobrzycka, Anna M. Witkowska, Beata Mackowiak-Matejczyk, Tomasz Kamil Sledziewski, Maciej Kinalski and Slawomir J. Terlikowski
    Citation: Journal of Ovarian Research 2016 9:43
  4. Serum levels of CA125 measured before any treatment have been evaluated in epithelial ovarian cancer (EOC) as a predictor of patient survival; however, results in survival index are controversial, as CA125 lev...

    Authors: Flavia Morales-Vásquez, Enrique Pedernera, Jesús Reynaga-Obregón, Horacio Noé López-Basave, María José Gómora, Elisa Carlón, Sandra Cárdenas, Raúl Silva-Ayala, Miguel Almaraz and Carmen Méndez
    Citation: Journal of Ovarian Research 2016 9:41
  5. Prenatal testosterone (T) excess from days 30-90 of gestation disrupts gonadotropin surge and ovarian follicular dynamics and induces insulin resistance and functional hyperandrogenism in sheep. T treatment fr...

    Authors: A Veiga-Lopez, J Moeller, D. H. Abbott and V Padmanabhan
    Citation: Journal of Ovarian Research 2016 9:39
  6. A major hurdle incurrent to the human clinical application of conditionally replicative adenovirus (CRAd)-based virotherapy agents is their limited therapeutic efficacy. In this study we evaluated whether armi...

    Authors: Ahmad Mohammad Ashshi, Adel Galal El-Shemi, Igor P. Dmitriev, Elena A. Kashentseva and David T. Curiel
    Citation: Journal of Ovarian Research 2016 9:38
  7. Ovarian endometriomas affect a substantial proportion of women of reproductive age who may have a potential risk of diminished ovarian reserve (DOR) after ovarian cystectomy. Here, we investigated the risk fac...

    Authors: Rie Ozaki, Jun Kumakiri, Andrea Tinelli, Grigoris F. Grimbizis, Mari Kitade and Satoru Takeda
    Citation: Journal of Ovarian Research 2016 9:37
  8. Normal development of reproductive organs is crucial for successful reproduction. In mice the early ovarian developmental process occurs during the embryonic and postnatal period and is regulated through a ser...

    Authors: Hannah M. Wear, Matthew J. McPike and Karen H. Watanabe
    Citation: Journal of Ovarian Research 2016 9:36
  9. Recently, vitamin D3 (1alpha, 25-dihydroxyvitamin D) has shown its capability to take part in many extraskeletal functions and its serum levels have been related to patient survival rate and malignancy of many ty...

    Authors: Francesca Uberti, Vera Morsanuto, Debora Lattuada, Barbara Colciaghi, Andrea Cochis, Alessandro Bulfoni, Paola Colombo, Giorgio Bolis and Claudio Molinari
    Citation: Journal of Ovarian Research 2016 9:34
  10. Melatonin is an indolamine produced by the pineal gland and it can exert a potent antioxidant effect. Its free radical scavenger properties have been used to advantage in different organ transplants in animal ...

    Authors: M. E. Shiroma, N. M. Botelho, L. L. Damous, E. C. Baracat and J. M. Soares-Jr
    Citation: Journal of Ovarian Research 2016 9:33
  11. Cell lines are very useful for both clinical and basic research. The establishment of ovarian, malignant tumor cell lines with aggressive histology is especially important. We describe the establishment and ch...

    Authors: Takashi Yamada, Kimiaki Hattori, Hidetoshi Satomi, Tadashi Okazaki, Hiroshi Mori and Yoshinobu Hirose
    Citation: Journal of Ovarian Research 2016 9:32
  12. High-Grade Serous Ovarian Carcinoma (HGSOC) is the predominant histotype of epithelial ovarian cancer (EOC), characterized by advanced stage at diagnosis, frequent TP53 mutation, rapid progression, and high re...

    Authors: Chiara Mignogna, Nicoletta Staropoli, Cirino Botta, Carmela De Marco, Antonia Rizzuto, Michele Morelli, Annalisa Di Cello, Renato Franco, Caterina Camastra, Ivan Presta, Natalia Malara, Angela Salvino, Pierfrancesco Tassone, Pierosandro Tagliaferri, Tullio Barni, Giuseppe Donato…
    Citation: Journal of Ovarian Research 2016 9:31
  13. The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Al...

    Authors: Gloria Mittica, Sonia Capellero, Sofia Genta, Celeste Cagnazzo, Massimo Aglietta, Dario Sangiolo and Giorgio Valabrega
    Citation: Journal of Ovarian Research 2016 9:30
  14. The aim of this study was to compare the efficacy of antagonist rescue protocol (replacing GnRH agonist with GnRH antagonist and reducing the dose of gonadotropins) combined with cabergoline versus cabergoline...

    Authors: Usama M. Fouda, Ahmed M. Sayed, Hesham S. Elshaer, Bahaa Eldin M. Hammad, Mona M. Shaban, Khaled A. Elsetohy and Mohamed A. Youssef
    Citation: Journal of Ovarian Research 2016 9:29
  15. Chemotherapy resistance presents a difficult challenge in treating epithelial ovarian cancer patients, particularly when tumors exhibit resistance to multiple chemotherapeutic agents. A few studies have shown ...

    Authors: J. R. Ribeiro, C. Schorl, N. Yano, N. Romano, K. K. Kim, R. K. Singh and R. G. Moore
    Citation: Journal of Ovarian Research 2016 9:28
  16. Mutation in the tumor suppressor gene TP53 is an early event in the development of high-grade serous (HGS) ovarian cancer and is identified in more than 96 % of HGS cancer patients. APR-246 (PRIMA-1MET) is the fi...

    Authors: Ã…sa Fransson, Daria Glaessgen, Jessica Alfredsson, Klas G. Wiman, Svetlana Bajalica-Lagercrantz and Nina Mohell
    Citation: Journal of Ovarian Research 2016 9:27
  17. Deficiency in Vitamin D3 (cholecalciferol) may predispose to some malignancies, including gonadal tumors and in experimental models vitamin D3 has been proven to inhibit the growth of cancer cells. To learn mo...

    Authors: Ahmed Abdelbaset-Ismail, Daniel Pedziwiatr, Ewa Suszyńska, Sylwia Sluczanowska-Glabowska, Gabriela Schneider, Sham S. Kakar and Mariusz Z. Ratajczak
    Citation: Journal of Ovarian Research 2016 9:26
  18. BH3 mimetics are a class of drugs that antagonize the Bcl-2 family of apoptosis inhibitors. We have previously shown that these compounds can potentiate the activity of carboplatin against several ovarian canc...

    Authors: Mohammed Najim Abed, Marwan Ibrahim Abdullah and Alan Richardson
    Citation: Journal of Ovarian Research 2016 9:25
  19. Recent findings have revealed that the female gonad may have regenerative activity with having germ line stem cells in juveniles and adults. Application of these germ line stem cells could be an alternative th...

    Authors: Yeon-Mi Lee, Tae-Ho Kim, Jeong-Hyeon Lee, Won-Jae Lee, Ryoung-Hoon Jeon, Si-Jung Jang, Sun-A Ock, Sung-Lim Lee, Bong-Wook Park and Gyu-Jin Rho
    Citation: Journal of Ovarian Research 2016 9:24
  20. The down-regulation of E-cadherin gene (CDH1) expression has been regarded as an important event in cancer invasion and metastasis. However, the association between CDH1 promoter methylation and ovarian cancer re...

    Authors: Qiang Wang, Bing Wang, Yun-mei Zhang and Wei Wang
    Citation: Journal of Ovarian Research 2016 9:23
  21. To evaluate the effects of an ovulation triggering agent, human chorionic gonadotropin (hCG), versus a gonadotropin-releasing hormone agonist (GnRHa) on early embryo development in vitro using a time-lapse system...

    Authors: Ali Sami Gurbuz, Funda Gode, Mehmet Sukru Uzman, Betul Ince, Melek Kaya, Necati Ozcimen, Emel Ebru Ozcimen and Ali Acar
    Citation: Journal of Ovarian Research 2016 9:22
  22. The critical role of the immune system in controlling cancer progression has become evident and immune modulatory therapy is now approved for clinical use. However, while the majority of studies on the inflamm...

    Authors: Sebastian Lundgren, Jonna Berntsson, Björn Nodin, Patrick Micke and Karin Jirström
    Citation: Journal of Ovarian Research 2016 9:21
  23. Ovarian cancer (OVC) is the deadliest of all gynecologic cancers, primarily as a consequence of asymptomatic progression. The complex nature of OVC creates challenges for early detection, and there is a lack o...

    Authors: Ayala Tamir, Anju Gangadharan, Sakshi Balwani, Takemi Tanaka, Ushma Patel, Ahmed Hassan, Stephanie Benke, Agnieszka Agas, Joseph D’Agostino, Dayoung Shin, Sunghoon Yoon, Andre Goy, Andrew Pecora and K. Stephen Suh
    Citation: Journal of Ovarian Research 2016 9:20
  24. Breast cancer associated (BRCA) genes are critical for DNA repair. Mutations in BRCA1 and BRCA2 (BRCAm) result in loss of these repair mechanisms and potential carcinogenesis. Germline BRCAm are common in ovarian...

    Authors: Sudhir K. Unni, Marisa B. Schauerhamer, Rishi Deka, Jerzy E. Tyczynski, Ancilla W. Fernandes, Vanessa Stevens, Diana I. Brixner and David D. Stenehjem
    Citation: Journal of Ovarian Research 2016 9:18
  25. Amplified centrosomes are widely recognized as a hallmark of cancer. Although supernumerary centrosomes would be expected to compromise cell viability by yielding multipolar spindles that results in death-indu...

    Authors: Karuna Mittal, Da Hoon Choi, Sergey Klimov, Shrikant Pawar, Ramneet Kaur, Anirban K. Mitra, Meenakshi V. Gupta, Ralph Sams, Guilherme Cantuaria, Padmashree C. G. Rida and Ritu Aneja
    Citation: Journal of Ovarian Research 2016 9:17
  26. Fertility-sparing surgery for patients with borderline ovarian tumors (BOTs) is still controversial. This study aimed to evaluate the oncological safety and fertility benefits in conservative surgery,as well a...

    Authors: Rui-fang Chen, Jun Li, Ting-ting Zhu, Hai-lin Yu and Xin Lu
    Citation: Journal of Ovarian Research 2016 9:16
  27. The ovulatory LH surge rapidly alters the expression of steroidogenesis-related genes such as steroidogenic acute regulatory protein (StAR) in granulosa cells (GCs) undergoing luteinization. We recently reported ...

    Authors: Ryo Maekawa, Lifa Lee, Maki Okada, Hiromi Asada, Masahiro Shinagawa, Isao Tamura, Shun Sato, Hiroshi Tamura and Norihiro Sugino
    Citation: Journal of Ovarian Research 2016 9:15
  28. Ovarian autotransplantation has shown increasing promise as a clinical method for the preservation of fertility and hormonal function. However, information regarding the success rate of this type of transplant...

    Authors: Lia Cruz V. C. Damásio, José Maria Soares-Júnior, Jairo Iavelberg, Gustavo A. R. Maciel, Manuel de Jesus Simões, Ricardo dos Santos Simões, Eduardo Vieira da Motta, Maria Cândida Pinheiro Baracat and Edmund C. Baracat
    Citation: Journal of Ovarian Research 2016 9:14
  29. In previous studies it has been found that in cell cultures of human adult ovaries there is a population of small stem cells with diameters of 2–4 Î¼m, which are present mainly in the ovarian surface epithelium...

    Authors: Irma Virant-Klun, Natasa Kenda-Suster and Spela Smrkolj
    Citation: Journal of Ovarian Research 2016 9:12
  30. There are no effective methods of diagnosis of early-stage ovarian cancer. Conservative care over patients at high risk of ovarian and breast cancers is ineffective. Prophylactic surgery is considered the best...

    Authors: Janusz Menkiszak, Anita Chudecka-Głaz, Jacek Gronwald, Aneta Cymbaluk-Płoska, Aleksander Celewicz, Maria Świniarska, Małgorzata Wężowska, Ryszard Bedner, Dorota Zielińska, Paulina Tarnowska, Jerzy Jakubowicz and Zbigniew Kojs
    Citation: Journal of Ovarian Research 2016 9:11
  31. Ovarian carcinomas, usually associated with sex hormones dysregulation, are the leading cause of gynecological neoplastic death. In normal ovaries, hormones play a central role in regulating cell proliferation...

    Authors: Maíra A. Lima, Suély V. da Silva and Vanessa M. Freitas
    Citation: Journal of Ovarian Research 2016 9:9
  32. Granulosa cell tumors (GCT) are a rare ovarian neoplasm but prognosis is poor following recurrence. Keratin intermediate filaments expressed in these tumors are a diagnostic marker, yet paradoxically, may also...

    Authors: Sarah K. Trisdale, Nicolette M. Schwab, Xiaoying Hou, John S. Davis and David H. Townson
    Citation: Journal of Ovarian Research 2016 9:8
  33. The editors of Journal of Ovarian Research would like to thank all of our reviewers who have contributed to the journal in Volume 8 (2015).

    Authors: Sham S. Kakar, Stefano Palomba, Benjamin K. Tsang and David T. Curiel
    Citation: Journal of Ovarian Research 2016 9:7
  34. Previous studies have reported that follicle-stimulating hormone (FSH) is often added to culture media to induce oocyte meiotic resumption and maturation and to improve subsequent embryonic development during ...

    Authors: Lei Yang, Qiang Wei, Wei Li, Qihui Xi, Xiaoe Zhao and Baohua Ma
    Citation: Journal of Ovarian Research 2016 9:6
  35. The fallopian tube epithelium is one of the potential sources of high-grade serous ovarian cancer (HGSC). The use of estrogen only hormone replacement therapy increases ovarian cancer (OVCA) risk. Despite estr...

    Authors: Georgette Moyle-Heyrman, Matthew J. Schipma, Matthew Dean, David A. Davis and Joanna E. Burdette
    Citation: Journal of Ovarian Research 2016 9:5
  36. Ovarian tissue preservation is proposed to patients at risk of premature ovarian failure, but this procedure still needs to be optimized. To limit injury during ovarian tissue cryopreservation, anti-apoptotic ...

    Authors: Laurie Henry, Maïté Fransolet, Soraya Labied, Silvia Blacher, Marie-Caroline Masereel, Jean-Michel Foidart, Agnès Noel, Michelle Nisolle and Carine Munaut
    Citation: Journal of Ovarian Research 2016 9:4
  37. Leiomyosarcoma of the uterus is an extremely rare but highly aggressive tumor that accounts for only 1–2 % of uterine malignancies, and is usually associated with a dismal outcome.

    Authors: Dong Soo Suh, Yoon Hwa Kim, Ka Yeong Yun, Nam Kyung Lee, Kyung Un Choi, Ki Hyung Kim and Man Soo Yoon
    Citation: Journal of Ovarian Research 2016 9:2
  38. A cohort study was performed to identify ovarian reserve markers (ORM) that predicts amenorrhea or oligomenorrhea 6 months after cyclophosphamide CTX in women with breast cancer.

    Authors: Ângela Marcon D’Avila, Vanderlei Biolchi, Edison Capp and Helena von Eye Corleta
    Citation: Journal of Ovarian Research 2015 8:82
  39. Despite its role in increasing the number of offspring during the lifetime of an individual animal, controlled ovarian hyperstimulation (COH) may have detrimental effects on oocyte development, embryo quality ...

    Authors: Sina Seifi Noferesti, Md. Mahmodul Hasan Sohel, Michael Hoelker, Dessie Salilew-Wondim, Ernst Tholen, Christian Looft, Franca Rings, Christiane Neuhoff, Karl Schellander and Dawit Tesfaye
    Citation: Journal of Ovarian Research 2015 8:81
  40. Recent studies have shown that microRNAs may regulate the ABCB1 gene (ATP-binding cassette, sub-family B [MDR/TAP], member 1). Computational programs have predicted that the 3’-untranslated region (3’-UTR) of ABC...

    Authors: Kai-Xuan Sun, Jin-Wen Jiao, Shuo Chen, Bo-Liang Liu and Yang Zhao
    Citation: Journal of Ovarian Research 2015 8:80

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.